Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-25 of 117 for your search:
Cancer Type/Condition:
Lung cancer, non-small cell
Trial Type:
Treatment
Trial Status:
Active
Sponsor of Trial:
NCI
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Randomized Study of Sublobar Resection With Versus Without Intraoperative Brachytherapy in High-Risk Patients With Stage I Non-Small Cell Lung Cancer
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
ACOSOG-Z4032
, SRCI, NCT00107172
2.
Phase III Randomized Study of Adjuvant Chemotherapy With or Without Bevacizumab in Patients With Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
ECOG-E1505
, E1505, SWOG-E1505, CALGB-E1505, CAN-NCIC-E1505, NCCTG-E1505, NCT00324805
3.
Phase III Randomized Study of Stereotactic Radiosurgery With Versus Without Whole-Brain Radiotherapy in Patients With Cerebral Metastases
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCCTG-N0574
, N0574, ACOSOG-N0574, NCT00377156
4.
Phase III Randomized Study of Lobectomy Versus Sublobar Resection in Patients With Small Peripheral Stage IA Non-Small Cell Lung Cancer
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CALGB-140503
, CALGB-140503, ECOG-40503, NCT00499330
5.
Phase III Randomized Study of High- Versus Standard-Dose Conformal Radiotherapy With Concurrent and Consolidation Chemotherapy Comprising Carboplatin and Paclitaxel in Patients With Newly Diagnosed, Unresectable Stage IIIA or IIIB Non-Small Cell Lung Cancer
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
RTOG-0617
, RTOG 0617, NCCTG-N0628, CALGB-30609, NCT00533949
6.
Phase III Randomized Study of Sunitinib Malate as Maintenance Therapy in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Combination Chemotherapy
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CALGB-30607
, CALGB 30607, NCT00693992
7.
Phase III Randomized Study of Talactoferrin in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer Who Have Failed Two of More Prior Treatment Regimens
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
NCI-09-C-0018
, 09-C-0018, AGENNIX-LF-0207, NCT00707304
8.
Phase III Randomized Study of Adjuvant Chemotherapy Versus Observation in Patients With Stage I Non-Small Cell Lung Cancer
Phase:
Phase III
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CALGB-30506
, CALGB-30506, NCT00863512
9.
Phase III Randomized Study of Carboplatin and Paclitaxel or Carboplatin, Paclitaxel, and Bevacizumab With Versus Without Concurrent Cetuximab in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Phase:
Phase III
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
SWOG-S0819
, S0819, NCT00946712
10.
Phase I/II Study of Vaccination Comprising a-1,3-Galactosyltransferase-Expressing Allogeneic Tumor Cells (HyperAcute™ Lung Cancer Vaccine) in Patients With Advanced Refractory or Recurrent Non-Small Cell Lung Cancer (Phase I is closed to accrual as of 10/06/09)
Phase:
Phase II, Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
NCI-04-C-0049
, NLGC-0101, NCT00075790
11.
Phase I/II (Phase I closed to accrual as of 09/29/2009) Study of Bortezomib, Paclitaxel, and Carboplatin With Concurrent Thoracic Radiotherapy in Patients With Unresectable Stage IIIA or IIIB Non-Small Cell Lung Cancer
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCCTG-N0321
, N0321, NCT00093756
12.
Phase I/II Pilot Study of Induction Therapy Comprising Cisplatin, Etoposide, and Radiotherapy With or Without Bevacizumab Followed by Consolidation Therapy Comprising Docetaxel and Bevacizumab in Patients With Newly Diagnosed, Unresectable, Stage III Non-Small Cell Lung Cancer
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
SWOG-S0533
, S0533, NCT00334815
13.
Phase I/II Study of Azacitidine and MS-275 in Patients With Recurrent Advanced Non-Small Cell Lung Cancer
Phase:
Phase II, Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
JHOC-J0658
, J0658, 7759, NCI-7759, JHOC-NA_00003114, NCT00387465
14.
Phase I/II Study of Erlotinib Hydrochloride and Cetuximab in Patients With Advanced Gastrointestinal, Head and Neck, Non-Small Cell Lung, or Colorectal Cancer
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
VU-VICC-GI-0622
, VICC-GI-0622, 6980, NCI-6980, NCT00397384
15.
Phase I/II Study of Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Pemetrexed Disodium in Patients With Advanced Non-Small Cell Lung Cancer, Breast Cancer, or Other Solid Tumors
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UCD-185
, UCDCC-185, UCD-200614714, NCT00470548
16.
Phase I/II Study of Induction Therapy Comprising Carboplatin, Paclitaxel, and Bevacizumab Followed by Chemoradiotherapy Comprising Thoracic Conformal Radiotherapy, Carboplatin, Paclitaxel, Bevacizumab, and Erlotinib Hydrochloride and Consolidation Therapy Comprising Bevacizumab and Erlotinib Hydrochloride in Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer (Phase I Closed to Accrual as of 1/3/2008)
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UNC-LCCC-0511
, LCCC 0511, NCT00280150
17.
Phase I/II Study of Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Carboplatin, and Concurrent Radiotherapy Followed by Consolidation Chemotherapy Comprising Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
VU-VICC-THO-0746
, VICC-THO-0746, NCT00544648
18.
Phase I/II Study of Nelfinavir Mesylate in Combination With Concurrent Thoracic Radiotherapy, Cisplatin, and Etoposide in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
Phase:
Phase II, Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UPCC-806285
, 806285, UPCC-04507, NCT00589056
19.
Phase I/II Study of Vorinostat, Paclitaxel, and Radiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Who Are Unable to Tolerate Cisplatin
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
UWCC-6600
, MERCK-UWCC-6600, 6600, UWCC-UW 6600, UWCC-08-0469-H/A, NCT00662311
20.
Phase I/II Study of Hydroxychloroquine in Combination With Carboplatin, Paclitaxel, and Bevacizumab in Patients With Recurrent Advanced Non-Small Cell Lung Cancer
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CINJ-030801
, 030801, NCT00728845
21.
Phase I/II Study of Stereotactic Body Radiotherapy in Medically Inoperable Patients With Centrally Located Stage I Non-Small Cell Lung Cancer
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
RTOG-0813
, RTOG 0813, NCT00750269
22.
Phase I/II Pilot Study of Genistein in Patients Undergoing Palliative External Beam Radiotherapy for Osseous Metastases
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UMN-2008LS035
, UMN-2008LS035, UMN-0803M29541, NCT00769990
23.
Phase I/II Calcitriol in Lung Cancer
Phase:
Phase II, Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Over 18
Sponsor:
NCI, Other
Protocol IDs:
UMCC 2008.042
, HUM%21242, NCT00794547
24.
Phase I/II Study of Everolimus and Whole-Brain Radiotherapy in Patients With Brain Metastasis From Non-Small Cell Lung Cancer
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
VU-VICC-THO-0772
, VICCTHO0772, IRB#090314, NCT00892801
25.
Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Who Have Finished First-Line Chemotherapy
Phase:
Phase II, Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI, Other
Protocol IDs:
EPROST-20057158
, SCCC-2005042, WIRB-20051678, NCT00534209
Select All on Page
1
Help with Results
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
RSS
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
